SCHEMBL21865727

SCHEMBL21865727

COC(=O)C1CC(OCCOc2ccc(-c3cc(=O)c4cc(N5CCCC5)cc(Cl)c4o3)cc2)C1

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 3/20 0.39
▸ BCHE P06276 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ USP8 P40818 1/20 0.38
▸ PARP1 P09874 1/20 0.37
▸ PARP2 Q9UGN5 1/20 0.37
▸ HRH3 Q9Y5N1 2/20 0.37
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21886455 0.91 ACHE (0.37) ACHEBCHEHRH3SIGMAR1
SCHEMBL21801353 0.89 MAOB (0.37) ACHEBCHEMAOBPARP1PARP2
SCHEMBL21801229 0.86 MAOB (0.42) BCHEMAOBHDAC3HDAC4HDAC1
SCHEMBL30744121 0.86 MAOB (0.42) BCHEMAOBHDAC3HDAC4HDAC1
SCHEMBL21801126 0.86 MAOB (0.42) BCHEMAOBHDAC3HDAC4HDAC1
SCHEMBL21801226 0.85 MAOB (0.41) ACHEBCHEMAOBPARP1PARP2
SCHEMBL21801185 0.84 MAOB (0.40) ACHEBCHEMAOBPARP1PARP2
SCHEMBL21801067 0.81 S1PR1 (0.35) ACHEBCHEHRH3SIGMAR1
SCHEMBL21801232 0.80 MAOB (0.44) BCHEMAOBPARP1PARP2HDAC3
SCHEMBL21801230 0.80 CYP3A4 (0.41) MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3849966-B1 FLAVONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE HOFFMANN LA ROCHE (CH) 2023-10-25 — — EP disclosed
WO-2020052774-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-03-19 — — WO disclosed
WO-2020053249-A1 FLAVONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-03-19 — — WO disclosed
Send feedback